Biotechs big winners in VC rebound
Biotechnology companies are leading a rebound in venture capital investment in the New York metro area, a new survey shows.
Investors put $380 million into 56 companies in the second quarter of this year, for a 63% jump in venture capital investment over the first quarter, according to the MoneyTree Survey by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association.
Vatican in favour of GM Food
: “The Vatican has made an endorsement of controversial genetically modified foods by declaring that they hold the answer to world starvation and malnutrition.”
Genetically engineered trees sprouting quietly… for now
Roll over John Muir and tell Johnny Appleseed the news: biotechnology is coming to the forest and orchard.
Antibiotics, The Next Generation
Few things are as inexorable as the march of bacterial resistance. When a person or animal is given an antibiotic, it kills enough pathogens to cure the illness. But bacteria that have mutated so they can resist the drug survive. The next time these bacteria cause an infection, the antibiotic is less likely to work. But that is drawing some biotech companies into the antibiotic research.